Rituxan hycela and Visual impairment - a phase IV clinical study of FDA data

Summary:

Visual impairment is reported as a side effect among people who take Rituxan hycela (hyaluronidase;rituximab), especially for people who are female, 40-49 old, also take Pantoprazole, and have Rheumatoid arthritis.

The phase IV clinical study analyzes which people have Visual impairment when taking Rituxan hycela. It is created by eHealthMe based on reports of 378 people who have side effects when taking Rituxan hycela from the FDA, and is updated regularly.

What is Rituxan hycela?

Rituxan hycela has active ingredients of hyaluronidase;rituximab. eHealthMe is studying from 380 Rituxan hycela users. Check the latest studies of Rituxan hycela.

What is Visual impairment?

Visual impairment is found to be associated with 2,250 drugs and 2,336 conditions by eHealthMe. Check the latest studies of Visual impairment.

eHealthMe: drug outcomes in the real world

eHealthMe runs one of the largest post-marketing drug safety studies in the world. We study millions of patients and 5,000 more each day. Our data-driven phase IV clinical trials have been referenced on 800+ peer-reviewed medical publications including The Lancet, Mayo Clinic Proceedings, and Nature. Tools to study our phase IV findings are available to the public, anonymous and free >>>.

On Aug, 31, 2026

378 people reported to have side effects when taking Rituxan hycela.
Among them, 11 people (2.91%) have Visual impairment.

Could Rituxan hycela cause Visual impairment?

Among these 11 people:

What is the gender of people who have Visual impairment when taking Rituxan hycela? *

female: 63.64 %
male: 36.36 %

What is the age of people who have Visual impairment when taking Rituxan hycela? *

What are other drugs people take besides Rituxan hycela? *

What are other side effects people have besides Visual impairment? *

Fatigue (feeling of tiredness): 11 people, 100.00%
Dizziness: 10 people, 90.91%
Nasopharyngitis (inflammation of the nasopharynx): 8 people, 72.73%
Infusion Related Reaction: 8 people, 72.73%
Lower Respiratory Tract Infection: 8 people, 72.73%
Malaise (a feeling of general discomfort or uneasiness): 8 people, 72.73%
Mobility Decreased (ability to move is reduced): 8 people, 72.73%
Headache (pain in head): 8 people, 72.73%
Stress And Anxiety: 8 people, 72.73%
Infection: 7 people, 63.64%

What are the existing conditions these people have? *

Rheumatoid Arthritis (a chronic progressive disease causing inflammation in the joints): 7 people, 63.64%
Crohn's Disease (a condition that causes inflammation of the gastrointestinal tract): 4 people, 36.36%
Psoriatic Arthropathy (inflammation of the skin and joints with kin condition which typically causes patches (plaques) of red, scaly skin to develop): 3 people, 27.27%
Psoriasis (immune-mediated disease that affects the skin): 3 people, 27.27%
Joint Pain: 3 people, 27.27%

* Approximation only. Some reports may have incomplete information.

Do you take Rituxan hycela and have Visual impairment?

- Check whether Visual impairment is associated with a drug or a condition
- Predict drug outcomes for up to one year with AI
- Get an AI agent to monitor your drugs continuously

Related studies:

Effectiveness of, long term effects of, and alternative drugs to Rituxan hycela:

Rituxan hycela (380 reports)

Visual impairment treatments and more:

Visual impairment (128,338 reports)

Browse all side effects of Rituxan hycela:

a b c d e f g h i j k l m n o p q r s t u v w x y z

Browse all the drugs that are associated with Visual impairment:

Visual impairment (2,250 drugs)

Browse all the conditions that are associated with Visual impairment:

Visual impairment (2,336 conditions)

How the study uses the data?

The study uses data from the FDA. It is based on hyaluronidase;rituximab (the active ingredients of Rituxan hycela) and Rituxan hycela (the brand name). Other drugs that have the same active ingredients (e.g. generic drugs) are not considered. Dosage of drugs is not considered in the study.

How to use the study?

DO NOT STOP MEDICATIONS without first consulting your doctor. If there are any serious or long term adverse effects discovered in the study, discuss the study with your doctor to ensure that proper medication management will be in place if applicable.

Who is eHealthMe?

With medical big data and proven AI/ML algorithms, eHealthMe provides a platform for everyone to run phase IV clinical trials. We study millions of patients and 5,000 more each day. Results of our real-world drug study have been referenced on 800+ peer-reviewed medical publications, including The Lancet, Mayo Clinic Proceedings, and Nature. Our analysis results are available to researchers, health care professionals, patients (testimonials), and software developers (open API).

WARNING, DISCLAIMER, USE FOR PUBLICATION

WARNING: Please DO NOT STOP MEDICATIONS without first consulting a physician since doing so could be hazardous to your health.

DISCLAIMER: All material available on eHealthMe.com is for informational purposes only, and is not a substitute for medical advice, diagnosis, or treatment provided by a qualified healthcare provider. All information is observation-only. Our phase IV clinical studies alone cannot establish cause-effect relationship. Different individuals may respond to medication in different ways. Every effort has been made to ensure that all information is accurate, up-to-date, and complete, but no guarantee is made to that effect. The use of the eHealthMe site and its content is at your own risk.

If you use this eHealthMe study on publication, please acknowledge it with a citation: study title, URL, accessed date.